Diabetes Mellitus, Type 2 Clinical Trial
— INDIGO-2Official title:
INDIGO-2: The Effect of High Water Intake on Glucose Regulation in Low-drinkers
Verified date | February 2020 |
Source | Arizona State University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Previous studies have indicated increased vasopressin due to hypertonic saline infusion impairs glucose regulation. The current study will examine the effect of low water intake on glucose regulation. No currently published study has investigated the acute effect of low water intake on glucose regulation using continuous glucose monitoring over the course of a full day. The aim of the study is to observe the effect of low water intake on glucose regulation in low drinkers. The study will study the glycemic responses to standardized meals in adults during an 11-hour period in two conditions: a) high water intake and b) low water intake. It is hypothesized that the area under the glucose curve will be greater in the low water intake trial as compared to the high water intake trial
Status | Completed |
Enrollment | 7 |
Est. completion date | December 19, 2019 |
Est. primary completion date | December 19, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 30 Years to 55 Years |
Eligibility |
Inclusion Criteria: - healthy sedentary participants - aged 30-55 years - body mass 27.5-35.0 kg·m2 - low water intake less than 1.5 L·day-1 (male) or 1.0 L·day-1 (female) - 24 h urine osmolality greater than 800 mmol/kg Exclusion Criteria: - diabetes HbA1c >6.5% - impaired liver or kidney function - cardiovascular disease - weight change of more than 3 kg in the past month - pregnancy - previous surgery on digestive tract - exercise >4 h/week |
Country | Name | City | State |
---|---|---|---|
United States | Arizona Biomedical Collaborative | Phoenix | Arizona |
Lead Sponsor | Collaborator |
---|---|
Arizona State University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Area under the curve of Glucose at lunch | 2-hour window starting right before the lunch meal (12:00 pm - 2:00 pm) | ||
Primary | Area under the curve of Glucose at Dinner | 2-hour window starting right before dinner (4:00 pm - 6:00 pm) | ||
Primary | Area under the curve of Glucose for the entire experiment | 11-hour window starting right before breakfast till 2 hours after dinner (7:00 am - 6:00 pm) | ||
Primary | Area under the curve of Copeptin for the entire experiment | 11-hour window starting right before breakfast till 2 hours after dinner (7:00 am - 6:00 pm) | ||
Primary | Area under the curve of Glucagon at lunch | 2-hour window starting right before the lunch meal (12:00 pm - 2:00 pm) | ||
Primary | Area under the curve of Glucagon at dinner | 2-hour window starting right before dinner (4:00 pm - 6:00 pm) | ||
Primary | Urinary glucose excretion | Entire 11-hour protocol 7:00 am - 6:00 pm | ||
Primary | Area Under the Curve for Plasma osmolality | the entire 11-hour protocol 7:00 am - 6:00 pm | ||
Secondary | Area under the curve of Insulin at lunch | 2-hour window starting right before the lunch meal (12:00 pm - 2:00 pm) | ||
Secondary | Area under the curve of Insulin at dinner | 2-hour window starting right before dinner (4:00 pm - 6:00 pm) | ||
Secondary | Area under the curve of Glucagon like peptide 1 at dinner | 2-hour window starting right before dinner (4:00 pm - 6:00 pm) | ||
Secondary | Area under the curve of Glucagon like peptide 1at lunch | 2-hour window starting right before the lunch meal (12:00 pm - 2:00 pm) | ||
Secondary | Area under the curve of plasma cortisol | the entire 11-hour protocol 7:00 am - 6:00 pm | ||
Secondary | Area under the curve for Thirst rating | Thirst assessed by Visual analog scale | the entire 11-hour protocol 7:00 am - 6:00 pm | |
Secondary | Mood assessment with a questionnaire | Assessed by Profile of mood state questionnaire | single measurement at baseline before the beginning of breakfast at 7:00 am and 1-hour before dinner meal at 3:00 pm |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |